Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint

• Olivier Riou, MD, PhD,
• Sophie Gourgou, MSc,,
• Thierry Conroy, MD

Affiliations

Olivier Riou, MD, PhD

From the * University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France

Sophie Gourgou, MSc,

† Biometrics Unit ICM, Montpellier Cancer Institute, Univ Montpellier, Montpellier, France

Thierry Conroy, MD

‡ Institut de Cancérologie de Lorraine, APEMAC, Université de Lorraine, Nancy, France.